Polymeric Diet Alone Versus Corticosteroids in the Treatment of Active Pediatric Crohn's Disease: A Randomized Controlled Open-Label Trial

Clinical Gastroenterology and Hepatology

Volumn 4, Issue 6, 2006, Pages 744-753

  Borrelli, Osvaldo ^a   Cordischi, Letizia ^a   Cirulli, Manuela ^a   Paganelli, Massimiliano ^a   Labalestra, Valeria ^a   Uccini, Stefania ^a   Russo, Paolo M ^a   Cucchiara, Salvatore ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HISTAMINE H2 RECEPTOR ANTAGONIST; METHYLPREDNISOLONE; PROTON PUMP INHIBITOR;

ABDOMINAL PAIN; ACNE; ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DEPRESSION; DIARRHEA; DIET THERAPY; DIETARY INTAKE; ENDOSCOPY; FEMALE; FLATULENCE; HEADACHE; HIRSUTISM; HISTOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; INSOMNIA; INTERMETHOD COMPARISON; INTESTINE MUCOSA; MALE; MOON FACE; MYOPATHY; NAUSEA; OBESITY; RANDOMIZED CONTROLLED TRIAL; REMISSION; STATISTICAL SIGNIFICANCE; STRIA; TREATMENT DURATION; TREATMENT OUTCOME; VOMITING;

ADMINISTRATION, ORAL; ADOLESCENT; CASEINS; CHILD; CHILD, PRESCHOOL; COLON; CROHN DISEASE; FEMALE; FOOD, FORMULATED; GLUCOCORTICOIDS; HUMANS; ILEUM; MALE; METHYLPREDNISOLONE; POLYMERS; TRANSFORMING GROWTH FACTOR BETA;

EID: 33744778418     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2006.03.010     Document Type: Article

References (46)

1. Kim S.C., and Ferry G.D. Inflammatory bowel diseases in pediatric and adolescent patients. clinical, therapeutic, and psychosocial considerations. Gastroenterology 126 (2004) 1550-1560
2. Rutgeerts P., Lofberg R., Malchow H., et al. A comparison of budesonide with prednisolone for active Crohn's disease. N Engl J Med 331 (1994) 842-845
3. Rutgeerts P.J. Review article. the limitations of corticosteroid therapy in Crohn's disease. Aliment Pharmacol Ther 15 (2001) 1515-1525
4. Faubion Jr. W.A., Loftus Jr. E.V., Harmsen W.S., et al. The natural history of corticosteroid therapy for inflammatory bowel disease. a population-based study. Gastroenterology 121 (2001) 255-260
5. Lichtenstein G.R., Cuffari C., Kane S.V., et al. Maintaining remissions across the lifespan. a roundtable discussion with Crohn's disease experts. Inflamm Bowel Dis 10 Suppl 2 (2004) S11-S21
6. Issenman R.M. Bone mineral metabolism in pediatric inflammatory bowel disease. Inflamm Bowel Dis 5 (1999) 192-199
7. Forbes A. Review article. Crohn's disease: the role of nutritional therapy. Aliment Pharmacol Ther 16 Suppl 4 (2002) 48-52
8. O'Morain C., Segal A.W., and Levi A.J. Elemental diet as primary treatment of acute Crohn's disease. a controlled trial. Br Med J 288 (1984) 1859-1862
9. Sanderson I.R., Udeen S., Davies P.S., et al. Remission induced by an elemental diet in small bowel Crohn's disease. Arch Dis Child 62 (1987) 123-127
10. Rigaud D., Cosnes J., Le Quintrec Y., et al. Controlled trial comparing two types of enteral nutrition in treatment of active Crohn's disease. elemental versus polymeric diet. Gut 32 (1991) 1492-1497
11. Gonzalez-Huix F., de Leon R., Fernandez-Banares F., et al. Polymeric enteral diets as primary treatment of active Crohn's disease. a prospective steroid controlled trial. Gut 34 (1993) 778-782
12. Ruuska T., Savilahti E., Maki M., et al. Exclusive whole protein enteral diet versus prednisolone in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr 19 (1994) 175-180
13. Ludvigsson J.F., Krantz M., Bodin L., et al. Elemental versus polymeric nutrition in pediatric Crohn's disease. a multicentre randomized controlled trial. Acta Paediatr 93 (2004) 327-335
14. Griffiths A.M., Ohlsson A., Sherman P.M., et al. Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease. Gastroenterology 108 (1995) 1056-1067
15. Griffiths A.M., and Buller H.B. Inflammatory bowel disease. In: Walker W.A., Durie P.R., Hamilton J.R., et al. (Eds). Pediatric gastrointestinal disease. Pathophysiology, diagnosis, management. 3rd ed (2000), BC Decker Inc, Hamilton 613-651
16. Hyams J.S., Ferry G., and Mandel F. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 12 (1991) 439-447
17. Cellier C., Sahmoud T., Froguel E., et al. Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives. Gut 35 (1994) 231-235
18. D'Haens G., Geboes K., Peeters M., et al. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 114 (1998) 262-267
19. Griffiths A.M. Specificities of inflammatory bowel disease in childhood. Best Pract Res Clin Gastroenterol 18 (2004) 509-523
20. Motil K., Grand R., Davis-Kraft L., et al. Growth retardation in inflammatory bowel disease. Gastroenterology 105 (1993) 681-691
21. Ballinger A.B., Azooz O., El-Haj T., et al. Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis. Gut 46 (2000) 694-700
22. Escher J.C., Taminiau J.A., Nieuwenhuis E.E., et al. Treatment of inflammatory bowel disease in childhood. best available evidence. Inflamm Bowel Dis 9 (2003) 34-58
23. Modigliani R., Mary J.Y., Simon J.F., et al. Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives. Gastroenterology 98 (1990) 811-818
24. Egan L.J., and Sandborn W.J. Advances in the treatment of Crohn's disease. Gastroenterology 126 (2004) 1574-1581
25. D'Haens G. Mucosal healing in pediatric Crohn's disease. the goal of medical treatment. Inflamm Bowel Dis 10 (2004) 479-480
26. Kundhal P.S., Critch J.N., Zachos M., et al. Pediatric Crohn Disease Activity Index. responsive to short-term change. J Pediatr Gastroenterol Nutr 36 (2003) 83-89
27. Landi B., Anh T.N., Cortot A., et al. Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives. Gastroenterology 102 (1992) 1647-1653
28. Olaison G., Sjodahl R., and Tagesson C. Glucocorticoid treatment in ileal Crohn's disease. relief of symptoms but not of endoscopically viewed inflammation. Gut 31 (1990) 325-328
29. Wyatt J., Vogelsang H., Hubl W., et al. Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet 341 (1993) 1437-1439
30. Tibble J.A., Sigthorsson G., Bridger S., et al. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 119 (2000) 15-22
31. Schreiber S., Nikolaus S., Hampe J., et al. Tumour necrosis factor alpha and interleukin 1beta in relapse of Crohn's disease. Lancet 353 (1999) 459-461
32. Munkholm P., Langholz E., Davidsen M., et al. Frequency of glucocorticoid resistance and dependency in Crohn's disease. Gut 35 (1994) 360-362
33. Heuschkel R.B., Menache C.C., Megerian J.T., et al. Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr 31 (2000) 8-15
34. Lochs H., Steinhardt H.J., Klaus-Wentz B., et al. Comparison of enteral nutrition and drug treatment in active Crohn's disease. Results of the European Cooperative Crohn's Disease Study. IV. Gastroenterology 101 (1991) 881-888
35. Fell J.M., Paintin M., Arnaud-Battandier F., et al. Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease. Aliment Pharmacol Ther 14 (2000) 281-289
36. Beattie R.M., Camacho-Hubner C., Wacharasindhu S., et al. Responsiveness of IGF-I and IGFBP-3 to therapeutic intervention in children and adolescents with Crohn's disease. Clin Endocrinol (Oxf) 49 (1998) 483-489
37. Yamamoto T., Nakahigashi M., Umegae S., et al. Impact of elemental diet on mucosal inflammation in patients with active Crohn's disease. cytokine production and endoscopic and histological findings. Inflamm Bowel Dis 11 (2005) 580-588
38. Heuschkel R.B., MacDonald T.T., Monteleone G., et al. Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease. Gut 47 (2000) 57-62
39. Breese E.J., Michie C.A., Nicholls S.W., et al. The effect of treatment on lymphokine-secreting cells in the intestinal mucosa of children with Crohn's disease. Aliment Pharmacol Ther 9 (1995) 547-552
40. Bannerjee K., Camacho-Hubner C., Babinska K., et al. Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease. J Pediatr Gastroenterol Nutr 38 (2004) 270-275
41. Wilschanski M., Sherman P., Pencharz P., et al. Supplementary enteral nutrition maintains remission in paediatric Crohn's disease. Gut 38 (1996) 543-548
42. Papadopoulou A., Rawashdeh M.O., Brown G.A., et al. Remission following an elemental diet or prednisolone in Crohn's disease. Acta Paediatr 84 (1995) 79-83
43. Heuschkel R.B. Enteral nutrition in Crohn disease. more than just calories. J Pediatr Gastroenterol Nutr 38 (2004) 239-241
44. Monteleone G., Pallone F., and MacDonald T.T. Smad7 in TGF-beta-mediated negative regulation of gut inflammation. Trends Immunol 25 (2004) 513-517
45. Schiffrin E.J., Yousfi M.E., Faure M., et al. Milk casein-based diet containing TGF-beta controls the inflammatory reaction in the HLA-B27 transgenic rat model. J Parenter Enteral Nutr 29 (2005) S141-S148
46. Zachos M., Tondeur M., and Griffiths A.M. A meta-analysis of enteral nutrition as primary therapy of active Crohn's disease. does formula composition influence efficacy?. Cochrane Database Syst Rev 3 (2001) 1-24